ReviewDiabetology & metabolic syndrome2025

GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation.

Maedeh Movahednasab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.